Treatment of behçet's disease with granulocyte and monocyte adsorption apheresis - 24/08/11
, Akira Gushi, MD a, Masahiro Iwata, MD a, Seita Fukumaru, MD, PhD a, Ryoko Sakamoto, MD a, Koichi Kawahara, PhD b, Ikuro Maruyama, MD, PhD b, Tamotsu Kanzaki, MD, PhD a
Reprint requests: Takuro Kanekura, MD, PhD, Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan.Kagoshima, Japan
Abstract |
The painful orogenital ulcerations of Behçet's disease are among the major symptoms of patients and are often intractable. We assessed the efficacy of granulocyte and monocyte adsorption apheresis therapy in two patients, a 21-year-old man with orogenital ulcerations and a 50-year-old woman with genital ulceration and abdominal pain. They underwent 5 and 8 granulocyte and monocyte adsorption apheresis treatments at 5-day intervals, respectively. The painful orogenital ulcerations of the man responded dramatically and the genital ulcer of the woman decreased in size and her abdominal pain was improved. Our results demonstrate that granulocyte and monocyte adsorption apheresis may be useful for treating orogenital ulcerations of Behçet's disease.
Le texte complet de cet article est disponible en PDF.Plan
 | This supplement is made possible through the generous support of Stiefel Laboratories for the American Academy of Dermatology. Funding sources: None. Conflicts of interest: None identified. |
Vol 51 - N° 2S
P. 83-87 - août 2004 Retour au numéro
Article précédent
- β-Lactam antibiotic-induced pseudoporphyria
- Thuy L Phung, Clare A Pipkin, Steven R Tahan, Diane S Chiu
- Dermoscopic features of melanoma on the scalp
- Iris Zalaudek, Bernd Leinweber, H.Peter Soyer, Gianluca Petrillo, Sergio Brongo, Giuseppe Argenziano
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?